Related Experiment Videos
Baclofen decreases methamphetamine self-administration in rats
Robert Ranaldi1, Kerry Poeggel
1Department of Psychology, Queens College, City University of New York, 65-30 Kissena Blvd., Flushing 11367, USA.
Abstract:
In the present study we tested the hypothesis that baclofen, a GABA-B receptor agonist, attenuates methamphetamine self-administration. Fifteen rats were trained to self-administer i.v. injections of methamphetamine (0, 0.0625, 0.125 and 0.25 mg/kg/injection) on a progressive ratio schedule of reinforcement, and then were tested under the influence of two doses of baclofen (2.5 or 5.0 mg/kg, i.p.). Baclofen significantly reduced break points at all doses of methamphetamine, producing a dose-orderly shift of the methamphetamine dose-response function to the right. These data suggest that pretreatment with baclofen reduces methamphetamine reward. These data are consistent with other studies showing impairment of drug reward after pretreatment with baclofen and add further support to the idea that GABA-B agonists may be useful in the treatment of drug addiction.
Insights
Baclofen, a GABA-B receptor agonist, significantly reduced methamphetamine self-administration in rats. These findings suggest baclofen may be a potential treatment for methamphetamine addiction.
Area of Science:
- Neuroscience
- Pharmacology
- Addiction Research
Background:
- Methamphetamine addiction remains a significant public health challenge.
- GABA-B receptors play a role in modulating reward pathways.
- Baclofen is a selective GABA-B receptor agonist with potential therapeutic applications.
Purpose of the Study:
- To investigate the effect of baclofen on methamphetamine self-administration in a rat model.
- To determine if baclofen can attenuate the rewarding effects of methamphetamine.
Main Methods:
- Rats were trained to self-administer methamphetamine intravenously on a progressive ratio schedule.
- Rats were pretreated with different doses of baclofen (2.5 or 5.0 mg/kg).
- Methamphetamine self-administration was assessed following baclofen administration.
Main Results:
- Baclofen significantly reduced the breakpoint for methamphetamine self-administration across all tested doses.
- A dose-dependent rightward shift in the methamphetamine dose-response function was observed.
- These results indicate that baclofen diminishes the reinforcing properties of methamphetamine.
Conclusions:
- Pretreatment with baclofen effectively reduces methamphetamine reward in rats.
- GABA-B agonists, like baclofen, show promise as a therapeutic strategy for treating drug addiction.
- Further research into GABA-B agonists could lead to novel addiction treatments.